Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 10951569)

1.

Human endothelial cells expressing polyoma middle T induce tumors.

Primo L, Roca C, Ferrandi C, Lanfrancone L, Bussolino F.

Oncogene. 2000 Jul 27;19(32):3632-41.

2.

Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system.

Sabapathy KT, Pepper MS, Kiefer F, Möhle-Steinlein U, Tacchini-Cottier F, Fetka I, Breier G, Risau W, Carmeliet P, Montesano R, Wagner EF.

J Cell Biol. 1997 May 19;137(4):953-63.

3.

Endothelial cell transformation by polyomavirus middle T antigen in mice lacking Src-related kinases.

Kiefer F, Anhauser I, Soriano P, Aguzzi A, Courtneidge SA, Wagner EF.

Curr Biol. 1994 Feb 1;4(2):100-9.

PMID:
7953508
4.

Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene.

Mühlner U, Möhle-Steinlein U, Wizigmann-Voos S, Christofori G, Risau W, Wagner EF.

Oncogene. 1999 Jul 22;18(29):4200-10.

5.

IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells.

Giraudo E, Arese M, Toniatti C, Strasly M, Primo L, Mantovani A, Ciliberto G, Bussolini F.

J Immunol. 1996 Sep 15;157(6):2618-23.

PMID:
8805665
6.
7.

Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen.

Besser D, Urich M, Sakaue M, Messerschmitt A, Ballmer-Hofer K, Nagamine Y.

Oncogene. 1995 Dec 7;11(11):2383-91.

PMID:
8570190
8.

Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs.

Tentori L, Vergati M, Muzi A, Levati L, Ruffini F, Forini O, Vernole P, Lacal PM, Graziani G.

Int J Oncol. 2005 Aug;27(2):525-35.

PMID:
16010436
9.

Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment.

Williams RL, Risau W, Zerwes HG, Drexler H, Aguzzi A, Wagner EF.

Cell. 1989 Jun 16;57(6):1053-63.

PMID:
2736622
10.

RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma development.

Sausville J, Molinolo AA, Cheng X, Frampton J, Takebe N, Gutkind JS, Feldman RA.

Clin Cancer Res. 2008 Jun 15;14(12):3948-55. doi: 10.1158/1078-0432.CCR-07-5152.

11.

Rac is essential in the transformation of endothelial cells by polyoma middle T.

Connolly JO, Soga N, Guo XL, Alvarez U, Hruska KA.

Cell Adhes Commun. 2000 May;7(5):409-22.

PMID:
10830619
12.

Endothelial cells transformed by SV40 T antigen cause Kaposi's sarcomalike tumors in nude mice.

O'Connell K, Landman G, Farmer E, Edidin M.

Am J Pathol. 1991 Oct;139(4):743-9.

13.

Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.

Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA, Castellino FJ.

Cancer Res. 2000 Oct 15;60(20):5839-47.

14.

Characterization of immortalized human umbilical and iliac vein endothelial cell lines after transfection with SV40 large T-antigen.

van Leeuwen EB, Veenstra R, van Wijk R, Molema G, Hoekstra A, Ruiters MH, van der Meer J.

Blood Coagul Fibrinolysis. 2000 Jan;11(1):15-25.

PMID:
10691096
15.

Umbilical cord endothelial cells expressing large T antigen: comparison with primary cultures and effect of cell age.

Fitzgerald U, Hettle S, MacDonald C, McLean JS.

In Vitro Cell Dev Biol Anim. 2000 Apr;36(4):222-7.

PMID:
10852346
16.

Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene.

Montesano R, Pepper MS, Möhle-Steinlein U, Risau W, Wagner EF, Orci L.

Cell. 1990 Aug 10;62(3):435-45.

PMID:
2379237
17.

Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1.

Corallini A, Possati L, Trabanelli C, Giraudo E, Rocchetti R, Talevi S, Caputo A, Bussolino F, Barbanti-Brodano G.

Carcinogenesis. 2003 Sep;24(9):1435-44. Epub 2003 Jul 4.

18.

Mice transgenic with SV40-late-promoter-driven Polyomavirus Middle T oncogene exclusively develop hemangiomas.

Xu Q, Chen W, Wang Z, Zheng J, Zhang Z.

Transgenic Res. 2009 Jun;18(3):399-406. doi: 10.1007/s11248-008-9232-1. Epub 2008 Dec 9.

PMID:
19067215
19.

Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors.

Garlanda C, Parravicini C, Sironi M, De Rossi M, Wainstok de Calmanovici R, Carozzi F, Bussolino F, Colotta F, Mantovani A, Vecchi A.

Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7291-5.

20.

Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice.

Bugge TH, Lund LR, Kombrinck KK, Nielsen BS, Holmbäck K, Drew AF, Flick MJ, Witte DP, Danø K, Degen JL.

Oncogene. 1998 Jun 18;16(24):3097-104.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk